ViviCells Int. Inc. is the nationâ��s first and only comprehensive family stem cell bank. - 500 Beiträge pro Seite
eröffnet am 27.01.09 14:01:39 von
neuester Beitrag 28.01.09 15:11:41 von
neuester Beitrag 28.01.09 15:11:41 von
Beiträge: 2
ID: 1.147.853
ID: 1.147.853
Aufrufe heute: 0
Gesamt: 1.323
Gesamt: 1.323
Aktive User: 0
ISIN: US9285351030 · WKN: A0Q1Z8 · Symbol: VCII
0,0001
USD
0,00 %
0,0000 USD
Letzter Kurs 25.08.23 Nasdaq OTC
Werte aus der Branche Dienstleistungen
Wertpapier | Kurs | Perf. % |
---|---|---|
6,6500 | +44,57 | |
10,000 | +17,10 | |
127,30 | +13,48 | |
23,550 | +13,06 | |
21,000 | +10,53 |
Wertpapier | Kurs | Perf. % |
---|---|---|
1,8150 | -11,03 | |
16,26 | -13,45 | |
19,010 | -23,96 | |
0,6300 | -30,00 | |
8,2100 | -89,71 |
http://www.vivicells.com/
http://www.neocells.com/
http://www.adultcells.com/
Symbol: VCII.PK / Kurs 0.15 USD
Meinungen?
http://www.neocells.com/
http://www.adultcells.com/
Symbol: VCII.PK / Kurs 0.15 USD
Meinungen?
January 28, 2009 09:09 AM Eastern Time
Bio-Matrix Scientific Group Signs Stem Cell Cryogenic Banking Contract with NeoCells, Inc. and AdultCells, Inc.
SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) (www.BMSN.us) today announced that it has entered into a Human Cell Tissue (HCT) Specimen Processing, Testing and Cryogenic Storage Contract with NeoCells, Inc. (NCI; www.neocells.com) and AdultCells, Inc. (ACI; www.adultcells.com).
Pursuant to this Contract, BMSN has agreed to:
(a) cryogenic banking and processing of umbilical cord blood and adult peripheral blood stem cells of clients from both NCI and ACI and
(b) cryogenic banking and processing of menstrual blood and other human stem cells of clients from both NCI and ACI upon BMSN’s approval.
As the contract requires BMSN to be compensated both initially and on a recurring basis for providing these services, the Company is excited about this contract’s potential to generate substantial first year as well as ongoing revenues.
“The execution of this contract demonstrates the substantial progress recently made by BMSN towards generating revenue,” said David Koos, Chairman and CEO. “The Company feels the NCI/ACI relationship demonstrates industry confidence in BMSN’s business model. Equally as important, the Company is confident this contract’s potential to generate revenue for BMSN can positively impact business expansion and share price, as revenues begin to replace outside investment as the primary source of operating capital.”
NeoCells and AdultCells bring a strong business management and marketing arm to the alliance. “NCI’s and ACI’s management have extensive background in the stem cell field, marketing cord blood and peripheral blood stem cell collection, along with cryogenic preservation storage services,” said Mr. Koos.
Fred Fitzsimmons, CEO of NeoCells, Inc. and AdultCells, Inc., envisions “the developing relationship between BMSN, NCI and ACI leading to the establishment of the premier stem cell cryogenic storage company in the U.S. BMSN’s state of the art facilities and NCI’s and ACI’s marketing expertise make for dynamic synergies,” he said.
About Bio-Matrix Scientific Group (OTCBB: BMSN)
Bio-Matrix Scientific Group Inc. is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. The company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation. Bio-Matrix' new 15,000 sq. ft. state-of-the-art facility, located in the heart of San Diego's biotechnology corridor, will house Bio-Matrix' two secure Cryogenic Stem Cell Bank, three research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories.
About NeoCells, Inc. and AdultCells, Inc.
NeoCells, Inc. and AdultCells, Inc. provide umbilical cord blood and adult peripheral blood stem cell collection, testing, processing, cryopreservation and storage services to their clients at the nation’s most affordable price. Corporate headquarters are in Evanston, IL and Client and Clinical Services Support are located in Palm Harbor, FL. NeoCells and AdultCells are subsidiaries of ViviCells International, Inc. (Symbol: VCII), an international stem cell preservation company providing families with high quality and affordable stem cell preservation services through its operating subsidiaries.
Bio-Matrix Scientific Group Signs Stem Cell Cryogenic Banking Contract with NeoCells, Inc. and AdultCells, Inc.
SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) (www.BMSN.us) today announced that it has entered into a Human Cell Tissue (HCT) Specimen Processing, Testing and Cryogenic Storage Contract with NeoCells, Inc. (NCI; www.neocells.com) and AdultCells, Inc. (ACI; www.adultcells.com).
Pursuant to this Contract, BMSN has agreed to:
(a) cryogenic banking and processing of umbilical cord blood and adult peripheral blood stem cells of clients from both NCI and ACI and
(b) cryogenic banking and processing of menstrual blood and other human stem cells of clients from both NCI and ACI upon BMSN’s approval.
As the contract requires BMSN to be compensated both initially and on a recurring basis for providing these services, the Company is excited about this contract’s potential to generate substantial first year as well as ongoing revenues.
“The execution of this contract demonstrates the substantial progress recently made by BMSN towards generating revenue,” said David Koos, Chairman and CEO. “The Company feels the NCI/ACI relationship demonstrates industry confidence in BMSN’s business model. Equally as important, the Company is confident this contract’s potential to generate revenue for BMSN can positively impact business expansion and share price, as revenues begin to replace outside investment as the primary source of operating capital.”
NeoCells and AdultCells bring a strong business management and marketing arm to the alliance. “NCI’s and ACI’s management have extensive background in the stem cell field, marketing cord blood and peripheral blood stem cell collection, along with cryogenic preservation storage services,” said Mr. Koos.
Fred Fitzsimmons, CEO of NeoCells, Inc. and AdultCells, Inc., envisions “the developing relationship between BMSN, NCI and ACI leading to the establishment of the premier stem cell cryogenic storage company in the U.S. BMSN’s state of the art facilities and NCI’s and ACI’s marketing expertise make for dynamic synergies,” he said.
About Bio-Matrix Scientific Group (OTCBB: BMSN)
Bio-Matrix Scientific Group Inc. is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. The company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation. Bio-Matrix' new 15,000 sq. ft. state-of-the-art facility, located in the heart of San Diego's biotechnology corridor, will house Bio-Matrix' two secure Cryogenic Stem Cell Bank, three research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories.
About NeoCells, Inc. and AdultCells, Inc.
NeoCells, Inc. and AdultCells, Inc. provide umbilical cord blood and adult peripheral blood stem cell collection, testing, processing, cryopreservation and storage services to their clients at the nation’s most affordable price. Corporate headquarters are in Evanston, IL and Client and Clinical Services Support are located in Palm Harbor, FL. NeoCells and AdultCells are subsidiaries of ViviCells International, Inc. (Symbol: VCII), an international stem cell preservation company providing families with high quality and affordable stem cell preservation services through its operating subsidiaries.
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
224 | ||
203 | ||
183 | ||
41 | ||
36 | ||
27 | ||
27 | ||
27 | ||
26 | ||
26 |
Wertpapier | Beiträge | |
---|---|---|
25 | ||
25 | ||
23 | ||
20 | ||
20 | ||
20 | ||
20 | ||
18 | ||
18 | ||
18 |